MedTrace Logo

Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever Patients

NCT05407181 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2022-06-07

No results posted yet for this study

Summary

Liver dysfunction marked by elevated alanine transaminase enzymes is quite common in dengue patients and subsequently affects the disease's severity and healing process. Unfortunately, liver function tests cannot always be done, especially in hospitals with limited facilities. In contrast, routine hematology tests are considered regular and inexpensive tests that can be performed on dengue patients. Therefore, this study aims to determine hematological parameters as markers of elevated liver enzymes in dengue patients.

Conditions

  • Dengue Fever

Interventions

OTHER

Blood and Liver Function test

Data was collected through routine blood and liver function tests using a hematology analyzer and ELISA, respectively.

Sponsors & Collaborators

  • Nurhasan Agung Prabowo

    lead OTHER

Principal Investigators

  • Nurhasan Agung Prabowo, MD · Universitas Sebelas Maret

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-03
Primary Completion
2022-06-03
Completion
2022-06-05

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05407181 on ClinicalTrials.gov